Kathleen
2011-01-30 11:11:59 UTC
To: ***@forbes.com, ***@drcarolgoodheart.com,
***@cdc.gov, ***@yale.edu, ***@columbia.edu,
***@nymc.edu, ***@ostp.gov,
***@princeton.edu, ***@fiu.edu,
***@hhs.fds.gov, ***@niaid.nih.gov,
***@niaid.nih.gov, ***@yahoogroups.com, ***@calea.org,
***@gmail.com, ***@usdoj.gov,
***@sbcglobal.net, ***@nejm.org, ***@courant.com,
***@cdc.gov, ***@ct.gov, ***@po.state.ct.us,
executive-***@nytimes.com, managing-***@nytimes.com, news-
***@nytimes.com, ***@nytimes.com, ***@nytimes.com,
***@nytimes.com, ***@cdc.gov, ***@optonline.net,
***@hotmail.com, ***@aol.com, ***@courant.com,
***@yahoo.com, ***@fff.org, ***@usdoj.gov,
***@ct.gov, ***@washpost.com, ***@washpost.com,
***@allegorypress.com, ***@po.state.ct.us,
***@comcast.net, ***@comcast.net, ***@po.state.ct.us,
***@charter.net, ***@po.state.ct.us,
***@po.state.ct.us, ***@ct.gov,
***@usdoj.gov, ***@yale.edu, ***@greenwich-
post.com, ***@yale.edu, ***@nswbc.org, ***@aol.com,
***@nytimes.com, ***@sbcglobal.net, ***@berkeley.edu,
***@tribune.com
Cc: ***@ucia.gov, dr-***@president.ir,
***@washpost.com, ***@newstimes.com, ***@hotmail.com,
***@aol.com, ***@gmail.com, ***@rms-law.com,
***@aol.com, ***@yahoo.com,
***@usdoj.gov, ***@usdoj.gov,
***@usdoj.gov, ***@yale.edu,
***@yale.edu, ***@yale.edu, ***@aldf.com,
***@idsociety.org, ***@theatlantic.com
Subject: Pfizer Sued by USDOJ, Who Actually *NEED* Their Drugs,
Neurontin/Lyrica
Date: Jan 30, 2011 6:07 AM
ARTICLE BELOW
BUT THE SCIENCE ACTUALLY SAYS:
No courage, no thinking = lawyers, Republicans,
psychiatrists, cops and market analysts are not able
to think logically, because they think *emotionally* -
LIKE GIRLS - and therefore need Neurotin/Lyrica.
===========================================
GABA-analogs, the science tells us,
have an application - as a treatment
for other psychotropics-induced brain
damage:
http://www.actionlyme.org/BRAINDAMAGE.htm
NEUROTOXIC DEGRADANTS of PSYCHOTROPICS
"Effects of haloperidol metabolites on neurotransmitter uptake and
release: possible role in neurotoxicity and tardive dyskinesia.
"These results suggest that HP metabolites bind to the transporters
for dopamine and serotonin, but are not transporter substrates. In
contrast to their potent effects on amine release, HPP+ and HPTP were
unable to release preloaded GABA from cortical synaptosomes. The
implications of these results concerning a possible role of HP
metabolites in the development of tardive dyskinesia are discussed."
http://www.ncbi.nlm.nih.gov/pubmed/9555021
▲Drug degradants (phenothiazine degradants) bind the GABA transporter,
adding to the agitation caused psychotropics.
And since Bipolar Dxs are epidemic (means:
"GIVE TWO OR THREE DRUGS INSTEAD OF
ONLY ONE, ESPECIALLY AS REGARDS THE
SPECIFIC, *DELIBERATE* BRAIN DAMAGING OF
*CHILDREN* BY THE SELF-ALLEGED 'CHILD
PROTECTIVE SERVICES'"), due also to the
epidemics of street drug and alcohol abuse
(a symptom of the Soviet States of America),
- you get a Dx of "Bipolar" if you are a
drug or alcohol abuser because the drugs
actually CAUSE what they initially are meant
to treat - then the real application of Lyrica/
Neurontin is for *intentional* drug abuse brain
damage, so don't believe the market analysts.
Allow me to state that differently:
The Market Analysts, who make the Development
choices in New York and not Groton, CT
(Pfizer Central Research), are not aware
of the fact that a HUGE potential application
of Neurontin/Lyrica, is in fact, scientifically,
the treatment of psychotropics-induced
brain damage.
Now. Think. Can Pfizer really make this
claim?
What would everyone say, if Pfizer said
"Lyrica/Neurontin is for the treatment of
the brain damage our other drugs cause."
Lyrica/Neurontin, technically, according to
the claims in the monograph and to the patent
office, has a HUGE potential application for
all recipients of malpractice treatments.
This fear-habit includes GOP Red-Staters and the
USDOJ, who are a bunch of lawyers, after all:
http://groups.google.com/group/sci.med.diseases.lyme/browse_thread/thread/3f05ed7252b66e5d?hl=en#
http://www.rawstory.com/rs/2010/12/conservatives-fear-center-brain/
"A study at University College London in the UK has found that
conservatives' brains have larger amygdalas than the brains of
liberals. Amygdalas are responsible for fear and other "primitive"
emotions. At the same time, conservatives' brains were also found to
have a smaller anterior cingulate -- the part of the brain responsible
for courage and optimism."
No courage, no thinking = lawyers, Republicans,
psychiatrists, cops, and market analysts are not
able to think logically, because they think
emotionally - LIKE GIRLS, or are potential candidates
for these drugs, the GABA analogs.
Drug addicts, people who are brain damaged
from Rx psychotropics, lawyers, psychiatrists,
cops, and Republicans are all in the same category.
But we have *all* seen that.
We *all* already knew that.
Aggression and Scientific Incompetence.
That's America.
-- -- --
Lyrica and Neurontin are probably drugs.
That means, the actual *SCIENTISTS* saw an
application.
There is no one to talk to at the USDOJ.
You now see why we make no progress.
You now see why this huge domain of
applications in Fungal-Viral Synergy
http://www.actionlyme.org/101016.htm
and the importance of Order of Infections:
Lyme-AIDS News (Dec 22, 2010):
"TLR engagement prior to virus infection influences MHC-I antigen
presentation in an epitope-dependent manner as a result of nitric
oxide release.
"Microorganisms contain PAMPs that can interact with different TLR-Ls.
Cooperative signals from these receptors may modify innate and
adaptive immune responses to invading pathogens. Therefore, a better
understanding of the role TLRs play in initiating host defense during
infections requires assessing the influence of multiple TLR engagement
on pAPC activation and antigen presentation. In this study, we
investigated the effects of combined TLR2, TLR3, or TLR4 engagement on
DC activation and the presentation of LCMV antigens focusing on the
major epitopes derived from NP and GP proteins encoded by the virus.
Our results demonstrate that combined TLR ligation affected antigen
presentation of NP(205-212), GP(33-41), and GP(276-286), but not
NP(396-404). The altered antigen presentation was associated with
changes in proteasomal activities and NO production as a result of TLR
engagement. Taken together, the data demonstrate that combined TLR
ligation could result in changes of innate effectors that may directly
influence the adaptive immune response."
http://www.ncbi.nlm.nih.gov/pubmed/21178114
Conclusion: The Order of Infection matters; See
http://www.actionlyme.org/GREATEST_IMITATOR_INTERVIEW.htm
cannot be unleashed.
Or, I guess we're saying "Won."
We cannot "win" the scientific/medical
future.
"Justice" won't let us.
Kathleen M. Dickson
http://www.actionlyme.org
http://www.relapsingfever.org
=========================================
Criminal Operator Pfizer Loses A Round Over Marketing of Neurontin But
No Jail For Corporate Executives For Violating RICO
http://www.nytimes.com/2011/01/29/business/29pfizer.html?_r=1&scp=1&sq=pfizer
told to pay&st=cse
Pfizer Told to Pay $142.1 Million Over Marketing of Epilepsy Drug
By BLOOMBERG NEWS
Published: January 28, 2011
Pfizer, the drug maker, has been ordered to pay a total of $142.1
million in damages for violating federal racketeering laws in the
marketing of its epilepsy drug Neurontin.
Add to Portfolio
* Pfizer Inc
Go to your Portfolio »
Judge Patti B. Saris of United States District Court in Boston upheld
a jury’s finding that the Kaiser Foundation Health Plan and Kaiser
Foundation Hospitals deserved the award over their claims that Pfizer
illegally promoted Neurontin for unapproved uses.
In her ruling on Thursday, Judge Saris tripled the jury’s award of
$47.3 million under a provision of the Racketeer Influenced and
Corrupt Organizations Act of 1970.
Kaiser officials claimed they were duped into believing that migraines
and bipolar disordercould be treated effectively with Neurontin,
approved in 1993 by the Food and Drug Administration for epilepsy.
Chris Loder, a Pfizer spokesman, said the company intended to appeal.
Kaiser, based in Oakland, Calif., claimed it was forced to pay $90
million more than it should have for the drug.
Pfizer currently faces more than 300 suits accusing it of illegally
promoting Neurontin or hiding its health risks. Lawyers for former
users of Neurontin contend the drug maker knew the medicine posed a
suicide risk and failed to disclose it to patients and doctors.
The Warner-Lambert Company developed and marketed Neurontin for
several years before Pfizer acquired the drug maker in 2000. Four
years later, Warner-Lambert pleaded guilty and agreed to pay $430
million to resolve off-label marketing allegations by the Justice
Department.
KMDickson
***@cdc.gov, ***@yale.edu, ***@columbia.edu,
***@nymc.edu, ***@ostp.gov,
***@princeton.edu, ***@fiu.edu,
***@hhs.fds.gov, ***@niaid.nih.gov,
***@niaid.nih.gov, ***@yahoogroups.com, ***@calea.org,
***@gmail.com, ***@usdoj.gov,
***@sbcglobal.net, ***@nejm.org, ***@courant.com,
***@cdc.gov, ***@ct.gov, ***@po.state.ct.us,
executive-***@nytimes.com, managing-***@nytimes.com, news-
***@nytimes.com, ***@nytimes.com, ***@nytimes.com,
***@nytimes.com, ***@cdc.gov, ***@optonline.net,
***@hotmail.com, ***@aol.com, ***@courant.com,
***@yahoo.com, ***@fff.org, ***@usdoj.gov,
***@ct.gov, ***@washpost.com, ***@washpost.com,
***@allegorypress.com, ***@po.state.ct.us,
***@comcast.net, ***@comcast.net, ***@po.state.ct.us,
***@charter.net, ***@po.state.ct.us,
***@po.state.ct.us, ***@ct.gov,
***@usdoj.gov, ***@yale.edu, ***@greenwich-
post.com, ***@yale.edu, ***@nswbc.org, ***@aol.com,
***@nytimes.com, ***@sbcglobal.net, ***@berkeley.edu,
***@tribune.com
Cc: ***@ucia.gov, dr-***@president.ir,
***@washpost.com, ***@newstimes.com, ***@hotmail.com,
***@aol.com, ***@gmail.com, ***@rms-law.com,
***@aol.com, ***@yahoo.com,
***@usdoj.gov, ***@usdoj.gov,
***@usdoj.gov, ***@yale.edu,
***@yale.edu, ***@yale.edu, ***@aldf.com,
***@idsociety.org, ***@theatlantic.com
Subject: Pfizer Sued by USDOJ, Who Actually *NEED* Their Drugs,
Neurontin/Lyrica
Date: Jan 30, 2011 6:07 AM
ARTICLE BELOW
BUT THE SCIENCE ACTUALLY SAYS:
No courage, no thinking = lawyers, Republicans,
psychiatrists, cops and market analysts are not able
to think logically, because they think *emotionally* -
LIKE GIRLS - and therefore need Neurotin/Lyrica.
===========================================
GABA-analogs, the science tells us,
have an application - as a treatment
for other psychotropics-induced brain
damage:
http://www.actionlyme.org/BRAINDAMAGE.htm
NEUROTOXIC DEGRADANTS of PSYCHOTROPICS
"Effects of haloperidol metabolites on neurotransmitter uptake and
release: possible role in neurotoxicity and tardive dyskinesia.
"These results suggest that HP metabolites bind to the transporters
for dopamine and serotonin, but are not transporter substrates. In
contrast to their potent effects on amine release, HPP+ and HPTP were
unable to release preloaded GABA from cortical synaptosomes. The
implications of these results concerning a possible role of HP
metabolites in the development of tardive dyskinesia are discussed."
http://www.ncbi.nlm.nih.gov/pubmed/9555021
▲Drug degradants (phenothiazine degradants) bind the GABA transporter,
adding to the agitation caused psychotropics.
And since Bipolar Dxs are epidemic (means:
"GIVE TWO OR THREE DRUGS INSTEAD OF
ONLY ONE, ESPECIALLY AS REGARDS THE
SPECIFIC, *DELIBERATE* BRAIN DAMAGING OF
*CHILDREN* BY THE SELF-ALLEGED 'CHILD
PROTECTIVE SERVICES'"), due also to the
epidemics of street drug and alcohol abuse
(a symptom of the Soviet States of America),
- you get a Dx of "Bipolar" if you are a
drug or alcohol abuser because the drugs
actually CAUSE what they initially are meant
to treat - then the real application of Lyrica/
Neurontin is for *intentional* drug abuse brain
damage, so don't believe the market analysts.
Allow me to state that differently:
The Market Analysts, who make the Development
choices in New York and not Groton, CT
(Pfizer Central Research), are not aware
of the fact that a HUGE potential application
of Neurontin/Lyrica, is in fact, scientifically,
the treatment of psychotropics-induced
brain damage.
Now. Think. Can Pfizer really make this
claim?
What would everyone say, if Pfizer said
"Lyrica/Neurontin is for the treatment of
the brain damage our other drugs cause."
Lyrica/Neurontin, technically, according to
the claims in the monograph and to the patent
office, has a HUGE potential application for
all recipients of malpractice treatments.
This fear-habit includes GOP Red-Staters and the
USDOJ, who are a bunch of lawyers, after all:
http://groups.google.com/group/sci.med.diseases.lyme/browse_thread/thread/3f05ed7252b66e5d?hl=en#
http://www.rawstory.com/rs/2010/12/conservatives-fear-center-brain/
"A study at University College London in the UK has found that
conservatives' brains have larger amygdalas than the brains of
liberals. Amygdalas are responsible for fear and other "primitive"
emotions. At the same time, conservatives' brains were also found to
have a smaller anterior cingulate -- the part of the brain responsible
for courage and optimism."
No courage, no thinking = lawyers, Republicans,
psychiatrists, cops, and market analysts are not
able to think logically, because they think
emotionally - LIKE GIRLS, or are potential candidates
for these drugs, the GABA analogs.
Drug addicts, people who are brain damaged
from Rx psychotropics, lawyers, psychiatrists,
cops, and Republicans are all in the same category.
But we have *all* seen that.
We *all* already knew that.
Aggression and Scientific Incompetence.
That's America.
-- -- --
Lyrica and Neurontin are probably drugs.
That means, the actual *SCIENTISTS* saw an
application.
There is no one to talk to at the USDOJ.
You now see why we make no progress.
You now see why this huge domain of
applications in Fungal-Viral Synergy
http://www.actionlyme.org/101016.htm
and the importance of Order of Infections:
Lyme-AIDS News (Dec 22, 2010):
"TLR engagement prior to virus infection influences MHC-I antigen
presentation in an epitope-dependent manner as a result of nitric
oxide release.
"Microorganisms contain PAMPs that can interact with different TLR-Ls.
Cooperative signals from these receptors may modify innate and
adaptive immune responses to invading pathogens. Therefore, a better
understanding of the role TLRs play in initiating host defense during
infections requires assessing the influence of multiple TLR engagement
on pAPC activation and antigen presentation. In this study, we
investigated the effects of combined TLR2, TLR3, or TLR4 engagement on
DC activation and the presentation of LCMV antigens focusing on the
major epitopes derived from NP and GP proteins encoded by the virus.
Our results demonstrate that combined TLR ligation affected antigen
presentation of NP(205-212), GP(33-41), and GP(276-286), but not
NP(396-404). The altered antigen presentation was associated with
changes in proteasomal activities and NO production as a result of TLR
engagement. Taken together, the data demonstrate that combined TLR
ligation could result in changes of innate effectors that may directly
influence the adaptive immune response."
http://www.ncbi.nlm.nih.gov/pubmed/21178114
Conclusion: The Order of Infection matters; See
http://www.actionlyme.org/GREATEST_IMITATOR_INTERVIEW.htm
cannot be unleashed.
Or, I guess we're saying "Won."
We cannot "win" the scientific/medical
future.
"Justice" won't let us.
Kathleen M. Dickson
http://www.actionlyme.org
http://www.relapsingfever.org
=========================================
Criminal Operator Pfizer Loses A Round Over Marketing of Neurontin But
No Jail For Corporate Executives For Violating RICO
http://www.nytimes.com/2011/01/29/business/29pfizer.html?_r=1&scp=1&sq=pfizer
told to pay&st=cse
Pfizer Told to Pay $142.1 Million Over Marketing of Epilepsy Drug
By BLOOMBERG NEWS
Published: January 28, 2011
Pfizer, the drug maker, has been ordered to pay a total of $142.1
million in damages for violating federal racketeering laws in the
marketing of its epilepsy drug Neurontin.
Add to Portfolio
* Pfizer Inc
Go to your Portfolio »
Judge Patti B. Saris of United States District Court in Boston upheld
a jury’s finding that the Kaiser Foundation Health Plan and Kaiser
Foundation Hospitals deserved the award over their claims that Pfizer
illegally promoted Neurontin for unapproved uses.
In her ruling on Thursday, Judge Saris tripled the jury’s award of
$47.3 million under a provision of the Racketeer Influenced and
Corrupt Organizations Act of 1970.
Kaiser officials claimed they were duped into believing that migraines
and bipolar disordercould be treated effectively with Neurontin,
approved in 1993 by the Food and Drug Administration for epilepsy.
Chris Loder, a Pfizer spokesman, said the company intended to appeal.
Kaiser, based in Oakland, Calif., claimed it was forced to pay $90
million more than it should have for the drug.
Pfizer currently faces more than 300 suits accusing it of illegally
promoting Neurontin or hiding its health risks. Lawyers for former
users of Neurontin contend the drug maker knew the medicine posed a
suicide risk and failed to disclose it to patients and doctors.
The Warner-Lambert Company developed and marketed Neurontin for
several years before Pfizer acquired the drug maker in 2000. Four
years later, Warner-Lambert pleaded guilty and agreed to pay $430
million to resolve off-label marketing allegations by the Justice
Department.
KMDickson